Serum level of vascular endothelial growth factor in patients with obstructive sleep apnea hypopnea syndrome

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 27, Issue 2, 2007, Pages 157-160

  Ma, Jing ^a   Xu, Yongjian ^a   Zhang, Zhenxiang ^a   Liu, Huiguo ^a   Xiong, Weining ^a   Xu, Shuyun ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Obstructive sleep apnea hypopnea syndrome; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN A;

ADULT; ARTICLE; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROME; STATISTICAL MODEL;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 34248575957     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-007-0212-0     Document Type: Article

References (16)

1. Weiss J W, Launois S H, Anand A et al. Cardiovascular morbidity in obstructive sleep apnea. Prog Cardiovasc Dis, 1999, 41:367-376
2. Neufeld G, Cohen T, Gengrinovitch S et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J, 1999, 13:9-22
3. Ferrara N. Molecular and biological properties of vascular endothelial growth factor. J Mol Med, 1999, 77:527-543
4. The Sleep Respiratory Disease Group of the Respiratory Branch of Chinese Medical Association. Diagnosis and Treatment of Obstructive Sleep Apnea and Hypopnea Syndrom (Draft), Chin J Tuberc Respir Dis (Chinese), 2003,42:594-597
5. Schulz R, Hummel C, Heinemann S et al. Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med, 2002,165:67-70
6. Lavie L, Kraiczi H, Hefetz A et al. Plasma vascular endothelial growth factor in sleep apnea syndrome: effect s of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med, 2002, 165:1624-1628
7. Gozal D, zipton A J. Circulating vascular endothelial growth factor levels in patient s with obstructive sleep apnea syndrome. Sleep, 2002,25:59-65
8. Teramoto S, Kume H, Yamamoto H et al. Effects of oxygen administration on the circulation vascular endothelial growth factor levels in patient s wit h obstructive sleep apnea syndrome. Intern Med, 2003,42:681-685
9. Ziemer L L S, Koch C J, Maity A et al. Hypoxia and VEGF mRNA expression in human tumors. Neoplasia, 2001,3:500-508
10. Teramoto S, Kume H, Matsuse T et al. Oxygen administration improves the serum level of nitric oxide metabolites in patients with obstructive sleep apnea syndrome. Sleep Med, 2003,4:403-407
11. Ip M S, Lam B, Chan L Y et al. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med, 2001,164(10, Pt 1):1997-1998
12. Prabhakar N R. Sleep apneas: an oxidative stress? Am J Respir Crit Care Med, 2002, 165(7):859-860
13. Michiels C, Arnould T, Remade J. Endothelial cell responses to hypoxia: initiation of a cascade of cellular interactions. Biochim Biophys Acta, 2000, 1497:1-10
14. Davies R J O, Belt P J, Robers S J et al. Arterial blood pressure responses to graded transient arousal from sleep in normal humans. J Appl Physiol, 1993,74:1123-1130
15. Hornyak M, Cejnar M, Elam M et al. Muscle sympathetic nerve activity during sleep in man. Brain, 1991,114:1281-1295
16. Tharaux P L. Effect of sleep apnea syndrome on t he vascular endothelium. Rev Neural, 2003,159(11, Suppl):S102-106